RICHARD CLARK: Open Payments
NPI 1033421243 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,671 in 139 payments from 28 companies in 2025. Trend: 2023 $3,052 · 2024 $2,553 · 2025 $2,671
Food & beverage: $2,671
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $418 |
| ABBVIE INC. | 19 | $311 |
| Lilly USA, LLC | 16 | $306 |
| Novo Nordisk Inc | 11 | $221 |
| GlaxoSmithKline, LLC. | 12 | $202 |
| Phathom Pharmaceuticals, Inc. | 14 | $192 |
| PFIZER INC. | 11 | $145 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| Optinose US, Inc. | 4 | $73 |
| Amgen Inc. | 4 | $70 |
Products named: FARXIGA, MOUNJARO, VOQUEZNA, UBRELVY, JARDIANCE, Wegovy, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
